Findings

What do systematic reviews say?

1 questions · 1 findings · 1 reviews

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 1 · 100%High 0 · 0%

Clinical improvement D28b · people with mild/moderate/severe/critical COVID‐19

Tociliuzumab showed no clear difference in clinical improvement D28b compared with standard care/placebo (moderate certainty).

1 finding from 1 review

Interleukin‐6 blocking agents for treating COVID‐19: a living systematic review 2023 · Cochrane Headline outcomes only
RR 1.05 [1, 1.11]
15 studies · 6116 participants
Moderate